| Literature DB >> 31848274 |
Benjamin P Howden1,2,3, Timothy P Stinear4,2, Ian R Monk5, Jean Y H Lee5, Glen P Carter4,1,2, Sacha J Pidot4, Romain Guérillot4, Torsten Seemann4,1,2, Anders Gonçalves da Silva1,2, Timothy J Foster6.
Abstract
Staphylococcus epidermidis is a significant opportunistic pathogen of humans. Molecular studies in this species have been hampered by the presence of restriction-modification (RM) systems that limit introduction of foreign DNA. Here, we establish the complete genomes and methylomes for seven clinically significant, genetically diverse S. epidermidis isolates and perform the first systematic genomic analyses of the type I RM systems within both S. epidermidis and Staphylococcus aureus Our analyses revealed marked differences in the gene arrangement, chromosomal location, and movement of type I RM systems between the two species. Unlike S. aureus, S. epidermidis type I RM systems demonstrate extensive diversity even within a single genetic lineage. This is contrary to current assumptions and has important implications for approaching the genetic manipulation of S. epidermidis Using Escherichia coli plasmid artificial modification (PAM) to express S. epidermidis hsdMS, we readily overcame restriction barriers in S. epidermidis and achieved electroporation efficiencies equivalent to those of modification-deficient mutants. With these functional experiments, we demonstrated how genomic data can be used to predict both the functionality of type I RM systems and the potential for a strain to be electroporation proficient. We outline an efficient approach for the genetic manipulation of S. epidermidis strains from diverse genetic backgrounds, including those that have hitherto been intractable. Additionally, we identified S. epidermidis BPH0736, a naturally restriction-defective, clinically significant, multidrug-resistant ST2 isolate, as an ideal candidate for molecular studies.IMPORTANCE Staphylococcus epidermidis is a major cause of hospital-acquired infections, especially those related to implanted medical devices. Understanding how S. epidermidis causes disease and devising ways to combat these infections have been hindered by an inability to genetically manipulate clinically significant hospital-adapted strains. Here, we provide the first comprehensive analyses of the barriers to the uptake of foreign DNA in S. epidermidis and demonstrate that these are distinct from those described for S. aureus Using these insights, we demonstrate an efficient approach for the genetic manipulation of S. epidermidis to enable the study of clinical isolates for the first time.Entities:
Keywords: DNA methylation; Staphylococcus aureuszzm321990; coagulase-negative staphylococci; generalized transduction; genetic manipulation; genome analysis; type I restriction modification
Mesh:
Substances:
Year: 2019 PMID: 31848274 PMCID: PMC6918075 DOI: 10.1128/mBio.02451-19
Source DB: PubMed Journal: mBio Impact factor: 7.867
FIG 1Comparison of the structures and chromosomal locations of S. aureus and S. epidermidis type I restriction-modification systems. (A) S. aureus Newman_UoM (29, 32). (B) S. epidermidis BPH0736. For consistency, the chromosome is orientated forwards starting at the start codon of dnaA, and native type I RM systems are sequentially numbered.
FIG 2S. aureus native type I restriction-modification systems are lineage specific. The figure shows a maximum likelihood core SNP-based phylogeny of 128 closed S. aureus genomes originating from 40 STs, using Newman_UoM as the reference genome. Overlaid are the results of in silico multilocus sequence type (MLST), clonal cluster (CC), Bayesian analysis of population structure (BAPS), presence of CRISPR-Cas systems, and type I restriction-modification system HsdS variants. Bold red font indicates isolates with PacBio-characterized methylomes. Bold blue font indicates isolates with methylomes determined by DNA cleavage with purified enzyme. Boxes around strain names are colored according ST type. Open circles represent amino acid substitutions present in HsdS. An asterisk (*) indicates a truncated HsdS subunit. The scale bar indicates the number of nucleotide substitutions per site (bold) with an approximation of SNP rate (in parentheses).
Comparison of S. aureus and S. epidermidis type I restriction-modification systems
| RM system organized as a single | RM system organized as complete three-gene operon ( |
| Conserved, stable chromosomal location for each gene | Close proximity to |
| Most strains have two type I RM systems | Most strains have a single type I RM system |
| All strains have at least one type I RM system | Many (38.1%) strains have no type I RM system |
| Up to three functional type I RM systems per isolate | Up to three functional type I RM systems per isolate |
| 99.7% amino acid pairwise identity for all native HsdRs | At least five identified variants of HsdR |
| 99.3% amino acid pairwise identity for all native HsdMs | At least six identified variants of HsdM |
| At least 48 different variants of HsdS (8 likely imported from | At least 31 different variants of HsdS |
| Relative conservation of HsdS present within ST groups | No clear conservation of HsdS according to ST group |
| Conservation of HsdM provides redundancy, enabling interaction | Each HsdS is capable of interacting only with the corresponding |
| Complete three-gene |
Diversity of S. aureus type I restriction-modification system methylation profiles
Truncation at amino acid 203.
Truncation at amino acid 249.
Truncation at amino acid 8. Full amino acid translations of all 48 HsdS variants are accessible at Figshare (https://melbourne.figshare.com/articles/Sa_HsdS_48_fasta/7986956).
Isolate HsdS motifs were collated from publications by Monk et al. (9) and Cooper et al. (18) and from the REBASE database (33). HsdS names in bold black font have motifs determined by PacBio sequencing of the isolate after which the representative HsdS was named. HsdS names in bold blue font have motifs determined by DNA cleavage with purified restriction enzyme. The multilocus sequence types (MLSTs) in which each HsdS was found are listed according to the order in which they appear in the Fig. 2 phylogeny (top to bottom). STs within the same clonal complex (CC) are listed within square brackets; STs within parentheses represent single-locus variants of the ST group they are listed after. trunc, truncated; A (red), methylated adenine residue; T, complementary partner to methylated adenine residue. *, HUV05_RMS3 is carried on a plasmid, not integrated in the chromosome.
Diversity of S. epidermidis type I restriction modification methylation profiles
The ATCC 12228 type I RM system is nonfunctional, with a truncated hsdR gene, a complete hsdS gene, and no hsdM gene. All 64 isolates possessed the same incomplete type I RM system. The motif was identified based on the methylome determined for NIH4008 due to the presence of an HsdM protein capable of interacting with 12228 HsdS.
14.1.R1 type I RM system is nonfunctional, with truncated hsdR, complete hsdS, and no hsdM.
L1M substitution.
First 81 amino acids truncated.
S295P substitution.
Eleven amino acid substitutions (K26E, I56V, E59K, E171K, K174R, K175T, E178A, I193V, D201N, Y386F, and V434I). Amino acid translations of all 31 HsdS variants (https://melbourne.figshare.com/articles/Se_HsdS_31_fasta/7986911) and their interacting HsdMs (https://melbourne.figshare.com/articles/Se_HsdM_6_fasta/7986827) are accessible through Figshare.
Isolate HsdS motifs were collated from methylomes newly characterized in this study and from publications by Lee et al. (12) and Costa et al. (11). HsdS names in bold black font have motifs determined by PacBio sequencing of the isolate after which the representative HsdS was named. The multilocus sequence types (MLSTs) in which each HsdS was found are listed according to the order in which they appear in the Fig. 3 phylogeny (clockwise). ST185 is a single-locus variant of ST2. trunc, truncated; A (red), methylated adenine residue; T, complementary partner to methylated adenine residue.
FIG 3S. epidermidis type I restriction-modification systems are not conserved within lineages. The figure shows a maximum likelihood, core SNP-based phylogeny for 247 S. epidermidis genomes, including 7 newly closed reference genomes, 6 existing reference genomes, 156 genomes curated from the NCBI sequence read archive (SRA), 75 isolates from a study by Lee et al. (5); and the 3 draft genomes with methylation data (11). BPH0736 was used as the reference genome for analyses. Overlaid are the results of in silico multilocus sequence type (MLST), Bayesian analysis of population structure (BAPS), presence of CRISPR-Cas systems, and type I restriction-modification system HsdS variants. Bold red font indicates isolates with characterized methylomes. Isolates were from 70 recognized and two unclassified MLST groups. Boxes around strain names are colored according ST type; where background color is same as that of the BAPS group, the result indicates an ST represented by a single isolate. An asterisk (*) represents a truncated HsdS subunit. The scale bar indicates the number of nucleotide substitutions per site (bold) with an approximation of SNP rate (in parentheses).
FIG 4Plasmid artificial modification to overcome the type I RM systems in S. epidermidis. Biological triplicate data were determined for 5 μg of plasmid passaged through DC10B E. coli compared to the relevant E. coli PAM construct and transformed into S. epidermidis wild-type (WT) and ΔhsdS mutant strains. Error bars represent means ± standard deviations of results from three independent experiments. *, no transformants. (A) Electroporation of BPH0622-WT, BPH0662 ΔhsdS1, BPH0662 ΔhsdS2, and BPH0662 ΔhsdS1 ΔhsdS2 with plasmid pIMAY (left) or pRAB11 (right) isolated from DC10B and strain-specific E. coli Ec_Se662I (expressing BPH0662hsdMS1), Ec_Se662II (expressing BPH0662hsdMS2), and Ec_Se662I-II (expressing both BPH0662hsdMS1 and BPH0662hsdMS2). (B) Electroporation of RP62a-WT and RP62a ΔhsdS with plasmid pIMAY (left) or pRAB11 (right) isolated from DC10B and strain-specific E. coli Ec_SeRP62aI (expressing RP62ahsdMS). (C) Electroporation of BPH0736-WT and BPH0736 ΔhsdS with plasmid pIMAY Δ736hsdS isolated from DC10B and strain-specific E. coli Ec_Se736I (expressing BPH0736hsdMS). Note that pIMAY Δ736hsdS was used because neither pIMAY nor pRAB11 possessed any TRMs. (D) Number of S. epidermidis strain-specific HsdS TRMs present on each plasmid.
FIG 5S. epidermidis phage transduction is subject to type I restriction. Biological triplicate data were determined for phage transduction of Φ187-pRAB11 lysate transduced into S. epidermidis wild-type (WT) and ΔhsdS mutant strains. Error bars represent means ± standard deviations of results from three independent experiments. *, no transductants.